Xenetic Biosciences Inc

NASDAQ:XBIO  
0.42
-0.02 (-3.49%)
Earnings Announcements

Xenetic Biosciences Inc Reports Quarterly Loss Of $0.8 MILLION

Published: 11/10/2022 13:11 GMT
Xenetic Biosciences Inc (XBIO) - Xenetic Biosciences Inc - Ended the Quarter With $13.8 Million of Cash Expected to Fund Operations and Drive Expanded Pipeline Development Forward.
Xenetic Biosciences Inc - Net Loss for the Quarter Ended September 30, 2022 Was About $0.8 Million.
Revenue is expected to be $0.18 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.